The TMS Treatment for Postoperative Headache in GH Tumor
Status:
Not yet recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Headache is a very common main complaint of patients with GH pituitary tumor, which has
seriously affected the normal work and life of patients. Although the current surgery and
drugs have a certain effect on patients with headache, the overall effect is not satisfied.
However, the use of COX-2 inhibitors, non-steroidal anti-inflammatory drugs and other
analgesics are only effective for some patients with headaches, and long-term use has adverse
reactions. Therefore, it is necessary to seek new treatments for postoperative headaches in
patients with GH pituitary tumors. Transcranial magnetic stimulation (TMS) modulates the
excitability of the underlying cerebral cortex by applying a rapidly changing magnetic field
on the surface of the scalp. It is a relatively simple and safe method. It is currently
approved for treating depression, migraine, obsessive-compulsive disorder, and Alzheimer's
disease. Several small clinical studies have proven that rTMS can be used to prevent and
treat Headache. Therefore, this study aims to observe the efficacy and safety of TMS in the
treatment of postoperative headache in patients with GH pituitary tumors.